menu
    • menu

    Company profile for Acelyrin

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than...
    ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any one of us. ACELYRIN addresses the most basic human needs—to live a productive life free from diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AcelyrinUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    23371 Mulholland Dr, Los Angeles, California 91364
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acelyrin.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acelyrin-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alumis Completes Merger with Acelyrin
    Alumis Completes Merger with Acelyrin

    21 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/21/3085818/0/en/Alumis-Completes-Merger-with-ACELYRIN.html

    GLOBENEWSWIRE
    21 May 2025
    Share Share
    Activist investor fails to derail Alumis' Acelyrin merger
    Activist investor fails to derail Alumis' Acelyrin merger

    14 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/alumis-acelyrin-merger-back-track-after-shareholders-unswayed-activist-investor

    FIERCE BIOTECH
    14 May 2025
    Share Share
    Alumis Stockholders Approve Merger with Acelryin
    Alumis Stockholders Approve Merger with Acelryin

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080505/0/en/Alumis-Stockholders-Approve-Merger-with-ACELYRIN.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    ISS Recommends Acelyrin Stockholders Vote “FOR” Alumis Deal
    ISS Recommends Acelyrin Stockholders Vote “FOR” Alumis Deal

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3075586/0/en/Leading-Independent-Proxy-Advisory-Firm-ISS-Recommends-ACELYRIN-Stockholders-Vote-FOR-the-Proposed-Transaction-with-Alumis.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    Acelyrin Reiterates Benefits of Value-Maximizing Combo with Alumis
    Acelyrin Reiterates Benefits of Value-Maximizing Combo with Alumis

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072714/0/en/ACELYRIN-Reiterates-Benefits-of-Value-Maximizing-Combination-with-Alumis.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share
    Investor pressures Acelyrin to exit Alumis merger and liquidate
    Investor pressures Acelyrin to exit Alumis merger and liquidate

    30 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/investor-pressures-acelyrin-exit-alumis-merger-and-liquidate-slams-inexplicable-process

    FIERCE BIOTECH
    30 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search